Antivirus online is crucial to guard your computer from malware and also other threats. These types of programs damages your...
A TRUSTED PARTNER IN
Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized the highest quality products to battle malaria and other serious diseases.
We are a trusted partner to international public health agencies and organizations, including the World Health Organization, the Bill and Melinda Gates Foundation, UNICEF, and many others.
LEADING THE FIGHT
A challenge as complex as the Covid-19 pandemic requires
innovative, adaptable solutions. To meet the need for accurate,
reliable screening, we have a suite of products that includes
PCR, serology, and antigen testing.
If you want for being protected although browsing the web, you should choose the best no cost VPN to meet...
The at-home kits were divvied up and picked up by 19 different school districts in Erie County for distribution.
Based on sequence analysis and Omicron recombinant protein test, Omicron variant does not have influence on the target region of CareStart™ COVID-19 Rapid and PCR Tests.
Content Online casino Informatie Casinoland Facts What Greatest Free Spots System Substances? Casinoland Are located Gambling house Found at Real...
Content Brand-new Neo Gamstop Online casino Caribbean Hardly any Deposit Bonus offer Ignition Internet casino Online codes Seeking out Very...
INTRIVO DIAGNOSTICS SECURES NATIONAL DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL-SURGICAL FOR ACCESS BIO CARESTART™ COVID-19 TESTS
In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020.
Major supply chain agreements will ensure broad access to rapid testing solutions for patients and healthcare providers across US
Emergency Use Authorization Granted for CareStartTM Point-Of-Care Kit
Global Leader in Infectious Disease Diagnosis Receives FDA EUA for Serology Test Capable of Determining Subjects’ past COVID-19 Exposure and Immunoresponse within 10 Minutes
Global Leader in Infectious Disease Diagnosis Receives FDA EUA for Molecular Test that May Provide Laboratories Results in 83 Minutes or Less
GET IN TOUCH
US HERE AND
WE’LL BE TOUCH
We are always seeking to collaborate with forward-thinking individuals, organizations, and institutions.